The role of antidepressants in managing bipolar II disorder

Bipolar II Disorder: Modelling, Measuring and Managing, Second Edition

Volumn , Issue , 2012, Pages 100-113

  Goldberg, Joseph F ^a  

^a SILVER HILL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889089345     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139003315.011     Document Type: Chapter

References (49)

1. Altshuler, L. L., Suppes, T., Black, D. et al. (2003). Impact of antidepressant discontinuation at er acute bipolar depression remission on rates of depressive relapse at one-year follow-up. American Journal of Psychiatry, 160, 1252–1262.
2. Altshuler, L. L., Post, R. M., Hellemann, G. et al. (2009). Impact of antidepressant continuation at er acute positive or partial treatment response for bipolar depression: a blinded, randomized study. Journal of Clinical Psychiatry, 70, 450–457.
3. Amsterdam, J. D. and Brunswick, D. J. (2003). Antidepressant monotherapy for Bipolar Type II major depression. Journal of Affective Disorders, 5, 388–395.
4. Amsterdam, J. D. and Shults, J. (2005a). Fluoxetine monotherapy for Bipolar II and Bipolar NOS major depression: a double-blind, placebo-substitution, continuation study. International Clinical Psychopharmacology, 20, 257–264.
5. Amsterdam, J. D. and Shults, J. (2005b). Comparison of fluoxetine, olanzapine, and combined l uoxetine plus olanzapine initial therapy of Bipolar Type I and Type II major depression– lack of manic induction. Journal of Affective Disorders, 87, 121–130.
6. Amsterdam, J.D. and Shults, J. (2010a) Eficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomised, double-blind, placebosubstitution study. American Journal of Psychiatry, 167, 792–800.
7. Amsterdam, J. D. and Shults, J. (2010b). Ei cacy and mood conversion rate of short-term l uoxetine monotherapy of bipolar II major depressive episode. Journal of Clinical Psychopharmacology, 30, 306–311.
8. Amsterdam, J. D., Shults, J., Brunswick, D. J. and Hundert, M. (2004). Short-term fluoxetine monotherapy for Bipolar Type II or Bipolar NOS major depression– low manic switch rate. Bipolar Disorders, 6, 75–81.
9. Bauer, M. S., Wisniewski, S. R., Marangell, L. B. et al. for the STEP-BD Investigators (2006). Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Journal of Clinical Psychiatry, 67, 48–55.
10. Bond, D. J., Noronha, M. M., Kauer-Sant’Anna, M., Lam, R. W. and Yatham, L. N. (2008). Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta analysis. Journal of Clinical Psychiatry, 69, 1589–1601.
11. Calabrese, J. R., Ketter, T. A., Youakim, J. M., Tiller, J. M., Yang, R. and Frye, M. A. (2010). Adjunctive armodai nil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of concept study. Journal of Clinical Psychiatry, 71, 1363–1370.
12. Daray F. M., h ommi, S. B. and Ghaemi, S. N. (2010). The pharmacogenetics of antidepressant-induced mania: a systematic review and meta-analysis. Bipolar Disorders, 12, 702–706.
13. Diazgranados, N., Ibrahim, L., Brutsche, N. E. et al. (2010). A randomized add-on trial of an N -methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Archives of General Psychiatry, 67, 793–802.
14. Frye, M. A., Grunze, H., Suppes, T. et al. (2007). A placebo-controlled evaluation of adjunctive modai nil in the treatment of bipolar depression. American Journal of Psychiatry, 164, 1242–1249.
15. Frye, M. A., Helleman, G., McElroy, S. L. et al. (2009). Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. American Journal of Psychiatry, 166, 164–172.
16. Ghaemi, S. N., Rosenquist, K. J., Ko, J. Y. et al. (2004). Antidepressant treatment in bipolar versus unipolar depression. American Journal of Psychiatry, 161, 163–165.
17. Ghaemi, S. N., Ostacher, M. M., El-Mallakh, R. S. et al. (2010). Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. Journal of Clinical Psychiatry, 71, 372–380.
18. Goldberg, J. F. (2011). Antidepressant use and risk for suicide attempts in bipolar disorder. Journal of Clinical Psychiatry. 72, 1697.
19. Goldberg, J. F. and Truman, C. J. (2003). Antidepressant-induced mania: an overview of current controversies. Bipolar Disorders, 5, 407–420.
20. Goldberg, J. F. and Whiteside, J. E. (2002). The association between substance abuse and antidepressant-induced mania in bipolar disorder: a preliminary study. Journal of Clinical Psychiatry, 63, 791–795.
21. Goldberg, J. F., Burdick, K. E. and Endick, C. J. (2004). Preliminary randomized, double-blind, placebo-controlled trial of pramipexole for treatment-resistant bipolar depression. American Journal of Psychiatry, 161, 564–566.
22. Goldberg, J. F., Perlis, R. H., Ghaemi, S. N. et al. (2007). Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: i ndings from the STEP-BD. American Journal of Psychiatry, 164, 1348–1355.
23. Goldberg, J. F., Garno J. L., Callahan, A. M. et al. (2008). Overdiagnosis of bipolar disorder among substance use disorder inpatients with mood instability. Journal of Clinical Psychiatry, 69, 1751–1757.
24. Goldberg, J. F., Perlis, R. H., Bowden, C. L. et al. (2009). Mania symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. American Journal of Psychiatry, 166, 173–181.
25. Himmelhoch, J. M., Fhase, M. E., Mallinger, A. G. and Houck, P. (1991). Tranylcypromine versus imipramine in anergic bipolar depression. American Journal of Psychiatry, 148, 910–916.
26. Judd, L. L., Akiskal, H. S., Schettler, P. J. et al. (2003). A prospective investigation of the natural history of the long-term weekly symptomatic status of Bipolar II Disorder. Archives of General Psychiatry, 60, 261–269.
27. Leon, A., Solomon, D. A., Li, C. et al. (2011). Antidepressant use and risk for suicide attempts in bipolar disorder. Journal of Clinical Psychiatry, 72, 580–586.
28. Leverich, G. S., Altshuler, L. L., Frye, M. A. et al. (2006). Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilisers. American Journal of Psychiatry, 163, 232–239.
29. MacQueen, G. M., Young, L. T., Marriott, M. et al. (2002). Previous mood state predicts response and switch rates in patients with bipolar depression. Acta Psychiatrica Scandinavica, 105, 414–418.
30. Manwani, S. G., Pardo, T. B., Albanese, M. J. et al. (2006). Substance use disorder and other predictors of antidepressant-induced mania: a retrospective chart review. Journal of Clinical Psychiatry, 67, 1341–1345.
31. McElroy, S. L., Wesiler, R. H., Chang, W. et al. (2010). A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). Journal of Clinical Psychiatry, 71, 163–174.
32. Moller, H. J., Bottlender, R., Grunze, H., Strauss, A. and Wittmann, J. (2001). Are antidepressants less ef ective in the acute treatment of Bipolar I compared to unipolar depression? Journal of Af ective Disorders, 67, 141–146.
33. Nemerof, C. B., Evans, D. L., Gyulai, L. et al. (2001). Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. American Journal of Psychiatry, 158, 906–912.
34. Parker, G. and Brotchie, H. (2010). Do the old psychostimulant drugs have a role in managing treatment-resistant depression? Acta Psychiatrica Scandinavica, 121, 308–314.
35. Parker, G., Tully, L., Olley, A. and Hadzi- Pavlovic, D. (2006). SSRIs as mood stabilizers for Bipolar II Disorder? A proof of concept study. Journal of Af ective Disorders, 92, 205–214.
36. Peet, M. (1994). Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. British Journal of Psychiatry, 164, 549–550.
37. Post, R. M., Altshuler, L. L., Leverich, G. S. et al. (2006). Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. British Journal of Psychiatry, 189, 124–131.
38. Prien, R. F., Himmelhoch, J. M. and Kupfer, D. J. (1988). Treatment of mixed mania. Journal of Af ective Disorders 15, 9–15.
39. Rihmer, Z. and Pestality, P. (1999). Bipolar II disorder and suicidal behavior. Psychiatric Clinics of North America, 22, 667–673.
40. Sachs, G. S., Nierenberg, A. A., Calabrese, J. R. et al. (2007). Ef ectiveness of adjunctive antidepressant treatment for bipolar depression. New England Journal of Medicine, 356, 1711–1722.
41. Schneck, C. D., Miklowitz, D. J., Miyahara, S. et al. (2008). The prospective course of rapid-cycling bipolar disorder: i ndings from the STEP-BD. American Journal of Psychiatry, 165, 370–377.
42. Stoll, A. L., Mayer, P. V., Kolbrener, M. et al. (1994). Antidepressant-associated mania: a controlled comparison with spontaneous mania. American Journal of Psychiatry, 151, 1642–1645.
43. Tohen, M., Frank, E., Bowden, C. L. et al. (2009). The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disorders, 11, 453–473.
44. Tondo, L., Vázquez, G. and Baldessarini, R. J. (2010). Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatrica Scandinavica 121, 404–414.
45. Truman, C. J., Goldberg, J. F., Ghaemi, S. N. et al. (2007). Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Journal of Clinical Psychiatry, 68, 1472–1479.
46. Vieta, E., Martinez-Aran A, Goikolea, J. M. et al. (2002). A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. Journal of Clinical Psychiatry, 63, 508–512.
47. Young, L. T., Jof e, R. T., Robb, J. C. et al. (2000). Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. American Journal of Psychiatry, 157, 124–126.
48. Zarate, C. A. Jr., Payne, J. L., Singh, J. et al. (2004). Pramipexole for Bipolar II depression: a placebo-controlled proof of concept study. Biological Psychiatry 56, 54–60.
49. Zarate, C. A., Jr., Quiroz, J. A., Singh, J. B. et al. (2005). An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biological Psychiatry, 57, 430–432.